Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of CJ-40001 vs NESP in Healthy Male Volunteers
NCT03542916Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Oct 2014
- Primary completion
- Nov 2014
- Modality
- Biologic, rProtein (Recombinant Protein), Biosimilar
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of darbepoetin alfa biosimilar in anemia (2 arms), sponsored by HK inno.N Corporation. Primary endpoints: Maximum Observed Serum Concentration and Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration. Started Oct 2014; status: completed.
02
Drugs
darbepoetin alfa biosimilar
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03542916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542916.